Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy
- PMID: 11835525
- PMCID: PMC6807889
- DOI: 10.1002/jcla.2035
Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy
Abstract
The mechanism of mesangial IgA deposition is poorly understood in IgA nephropathy (IgAN). Abnormal glycosylation of carbohydrate moieties in the hinge region of the IgA molecule has recently attracted much attention. In this report, we studied galactosylation and sialylation profiles in kappa- and lambda-IgA1 from patients with IgAN. Total serum IgA1 was isolated from patients with IgAN or healthy controls by jacalin-affinity chromatography. Six fractions of molecular weight (MW) 50-1,000 kDa were separated by fast protein liquid chromatography (FPLC). Four lectin-binding assays were used to study the sialylation and the presence of terminal galactose or N-acetylgalactosamine (GalNAc) in the O-linked carbohydrate moieties of kappa- or lambda-IgA1. Maackia amurensis agglutinin (MAA) and Sambucus nigra agglutinin (SNA) lectin recognize alpha(2,3)- and alpha(2,6)-linked sialic acid, respectively. Peanut agglutinin (PNA) and Helix aspersa (HA) lectin recognize terminal galactose and GalNAc, respectively. Reduced HA was demonstrated in macromolecular kappa or lambda-IgA1 (300-825 kDa) isolated from patients with IgAN (P < 0.05 compared with healthy controls). Lambda- but not kappa-IgA1 from patients with IgAN bound less to PNA (P < 0.05). The alpha(2,3)-linked sialic acid content in lambda- but not kappa-IgA1 of MW 150-610 kDa from patients was higher than that of controls (P < 0.005). The alpha(2,6)-linked sialic acid content in lambda-IgA1 (300-825 kDa) and kappa-IgA1 (150-610 kDa) from patients was also higher than that of controls. This unusual glycosylation and sialylation pattern of the lambda-IgA1 may have important implications for the pathogenesis of IgAN, as both the masking effect of sialic acid on galactose and the reduced galactosylation will hinder the clearance of macromolecular lambda-IgA1 by asialoglycoprotein receptor of hepatocytes. The negative charge from sialic acid may also favor mesangial deposition of macromolecular lambda-IgA1 in IgAN.
Copyright 2002 Wiley‐Liss, Inc.angial IgA deposition is poorly understood in IgA ne
Similar articles
-
Increased sialylation of polymeric immunoglobulin A1: mechanism of selective glomerular deposition in immunoglobulin A nephropathy?J Lab Clin Med. 1999 Feb;133(2):152-60. doi: 10.1016/s0022-2143(99)90008-2. J Lab Clin Med. 1999. PMID: 9989767
-
Glycosylation profile of differently charged IgA1 and their binding characteristics to cultured mesangial cells in IgA nephropathy.Nephron Exp Nephrol. 2007;107(3):e107-18. doi: 10.1159/000109980. Epub 2007 Oct 23. Nephron Exp Nephrol. 2007. PMID: 17957128
-
The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy.Clin Exp Immunol. 2005 Dec;142(3):569-75. doi: 10.1111/j.1365-2249.2005.02949.x. Clin Exp Immunol. 2005. PMID: 16297170 Free PMC article.
-
The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.Nephrology (Carlton). 2007 Jun;12(3):275-84. doi: 10.1111/j.1440-1797.2007.00797.x. Nephrology (Carlton). 2007. PMID: 17498123 Review.
-
Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy.Clin Exp Nephrol. 2008 Oct;12(5):332-338. doi: 10.1007/s10157-008-0054-5. Epub 2008 Apr 12. Clin Exp Nephrol. 2008. PMID: 18404247 Review.
Cited by
-
Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes.J Biol Chem. 2014 Feb 21;289(8):5330-9. doi: 10.1074/jbc.M113.512277. Epub 2014 Jan 7. J Biol Chem. 2014. PMID: 24398680 Free PMC article.
-
Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Correlation with Oxford MEST-C Scores.J Clin Med. 2023 Nov 28;12(23):7361. doi: 10.3390/jcm12237361. J Clin Med. 2023. PMID: 38068413 Free PMC article.
-
Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers.Proteomics Clin Appl. 2013 Oct;7(9-10):618-31. doi: 10.1002/prca.201300024. Epub 2013 Sep 9. Proteomics Clin Appl. 2013. PMID: 23857728 Free PMC article. Review.
-
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.Front Immunol. 2016 Apr 12;7:117. doi: 10.3389/fimmu.2016.00117. eCollection 2016. Front Immunol. 2016. PMID: 27148252 Free PMC article. Review.
-
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1.J Clin Invest. 2008 Feb;118(2):629-39. doi: 10.1172/JCI33189. J Clin Invest. 2008. PMID: 18172551 Free PMC article.
References
-
- Lai KN, Lai FM, Chui SH, et al. 1987. Studies of lymphocyte subpopulations and immunoglobulin production in IgA nephropathy. Clin Nephrol 28:281–287. - PubMed
-
- Sakai H, Nomoto Y, Arimori S, Komori K, Inouye H, Tsuji K. 1979. Increase of IgA‐bearing peripheral blood lymphocytes in the families of patients with IgA nephropathy. Am J Clin Pathol 72:452–456. - PubMed
-
- Schena FP, Mastrolitti G, Fracasso AR, Pastore A, Ladisa N. 1986. Increased immunoglobulin‐secreting cells in the blood of patients with active idiopathic IgA nephropathy. Clin Nephrol 26:163–168. - PubMed
-
- Egido J, Sancho J, Mampaso F, et al. 1980. A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger disease and Schönlein‐Henoch syndrome. Proc Eur Dial Transpl Assoc 17:660–666. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous